A shocking revelation has emerged in the medical field, leaving many concerned and questioning the ethics of certain practices. Doctors' duty of care, a sacred principle, is being challenged by reports of its potential commodification.
The Malaysian Medical Association (MMA) has taken a strong stance, emphasizing that this duty is not for sale. This comes in response to allegations that some doctors have leased their Letters of Credentialing and Privileging (LCP) to aesthetic operators, raising serious ethical concerns.
Datuk Dr Thirunavukarasu Rajoo, the MMA president, expressed deep concern over these reports, which also involve the sale of prescription medications like Ozempic and Mounjaro without proper medical assessments. He highlighted that such practices, if proven, constitute a severe breach of professional ethics and a violation of the duty of care owed to patients.
"MMA supports rigorous investigation and enforcement by the relevant authorities where breaches are identified. We must uphold the integrity of our profession."
Dr Thirunavukarasu emphasized the importance of maintaining patient trust by resisting commercial pressures. He clarified that an LCP is not a tradable document and that the duty of care remains with the holder, even when it's utilized by others.
"When a clinic operates under a doctor's name without genuine supervision, the responsibility doesn't vanish. The duty of care rests with the doctor, and this is non-negotiable."
He further explained the potential medico-legal consequences of such actions, stating that they could lead to serious legal repercussions under existing laws and professional regulations.
Additionally, Dr Thirunavukarasu raised concerns about the misuse of potent metabolic medications as quick cosmetic solutions. He emphasized that these medications, such as semaglutide and tirzepatide, were developed for specific clinical indications like diabetes and obesity management, and should not be seen as lifestyle shortcuts.
"Prescribing these medications without proper history-taking and risk assessment can expose patients to severe risks, from gastrointestinal symptoms and dehydration to more serious complications."
The inappropriate demand for these medications may also limit access for patients who genuinely need them for chronic disease management, he added.
MMA reminds all doctors that their professional responsibility is reflected in every prescription they sign and every facility operating under their name. Financial gains should never compromise clinical standards, whether it's a physical clinic, an aesthetic center, or a digital telemedicine platform.
"Medicine is not a transaction. Every interaction with a patient carries the weight of our professional oath."
Dr Thirunavukarasu advised the public to verify the registration status of their doctors and ensure that consultations include proper assessments and counseling. He emphasized that no medical procedure is risk-free and that informed consent requires a full disclosure of benefits, risks, and alternatives.
A recent investigation by SAYS revealed the dark side of these practices, where some alleged medical practitioners are endangering lives by selling prescription drugs without proper patient screening and renting out their licenses to fuel a black market in aesthetic clinics. This unethical behavior allows these practitioners to profit from the growing craze for slimming and beauty, raking in thousands of dollars each month.
"But here's where it gets controversial... Should we solely blame the practitioners, or is there a larger systemic issue at play?"
This raises important questions about the role of medical associations, regulatory bodies, and the public in ensuring ethical practice. How can we strike a balance between innovation and tradition in healthcare? These are the complex issues we must navigate to ensure patient safety and uphold the integrity of the medical profession.
What are your thoughts on this matter? Feel free to share your opinions and engage in a constructive discussion in the comments below!
